Avadel Pharmaceuticals (AVDL) P/E (2015 - 2026)
Avadel Pharmaceuticals (AVDL) P/E from Mar 31, 2015 to Feb 12, 2026. The TTM Avadel Pharmaceuticals (AVDL) P/E is -6.96K. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
P/E
Annual P/E change of Avadel Pharmaceuticals (AVDL)
| Year | P/E | Change |
|---|---|---|
| 2026 | -6.96K | +0.42% |
| 2025 | -6.93K | +33361.50% |
| 2024 | -20.71 | +199.30% |
| 2023 | -6.92 | +115.81% |
| 2022 | -3.21 | -47.62% |
| 2021 | -6.12 | -110.45% |
| 2020 | 58.57 | -789.49% |
| 2019 | -8.49 | +741.69% |
| 2018 | -1.01 | -124.15% |
| 2017 | 4.18 | -183.92% |
| 2016 | -4.98 | -66.24% |
| 2015 | -14.75 | N/A |
Comparison Avadel Pharmaceuticals (AVDL) P/E with competitors
Avadel Pharmaceuticals (AVDL) P/E is -6957.62.